Invivo Therapeutics Holdings Corp logo

Invivo Therapeutics Holdings Corp Share Price (NASDAQ: NVIV)

▲

-0.32

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 12 Feb 2024

Check the interactive Invivo Therapeutics Holdings Corp Stock chart to analyse performance

Invivo Therapeutics Holdings Corp Key Stats

Check Invivo Therapeutics Holdings Corp key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.3207
Open
$0.4081
Market Capitalization
$995.9K
Today's Volume
$1.8M
Revenue TTM
$0.0
EBITDA
$-9.8M
Earnings Per Share (EPS)
$-3.28
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-98.11%

Global Institutional Holdings in Invivo Therapeutics Holdings Corp

  • Name

    Holdings %

  • BlackRock Inc

    1.12%

  • Vanguard Group Inc

    1.01%

  • Geode Capital Management, LLC

    0.60%

  • Tower Research Capital LLC

    0.27%

  • Morgan Stanley - Brokerage Accounts

    0.01%

Analyst Recommendation on Invivo Therapeutics Holdings Corp Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Invivo Therapeutics Holdings Corp(by analysts ranked 0 to 5 stars)

About Invivo Therapeutics Holdings Corp

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.
Organization
Invivo Therapeutics Holdings Corp
Employees
6
CEO
Dr. Richard M. Toselli M.D.
Industry
Health Technology

Important FAQs about investing in NVIV Stock from India :

What is Invivo Therapeutics Holdings Corp share price today?

Invivo Therapeutics Holdings Corp share price today is as on at the close of the market. Invivo Therapeutics Holdings Corp share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Invivo Therapeutics Holdings Corp share?

Invivo Therapeutics Holdings Corp share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Invivo Therapeutics Holdings Corp stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Invivo Therapeutics Holdings Corp Stock (NVIV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Invivo Therapeutics Holdings Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Invivo Therapeutics Holdings Corp Shares .

What is the minimum amount required to buy Invivo Therapeutics Holdings Corp Stock (NVIV) from India?

Indian investors can start investing in Invivo Therapeutics Holdings Corp (NVIV) shares with as little as ₹88.185 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.85 in Invivo Therapeutics Holdings Corp stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Learn more about fractional shares .

What are the returns that Invivo Therapeutics Holdings Corp has given to Indian investors in the last 5 years?

Invivo Therapeutics Holdings Corp stock has given 0.0% share price returns and 19.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?